HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for HIV patients with kaposi sarcoma: drug shows promise in africa
Disease control CompletedThis study tested a drug called pomalidomide in 26 HIV-positive people with Kaposi sarcoma, a type of skin cancer. The drug works by boosting the immune system and stopping tumor growth. The goal was to see if it could shrink tumors and control the disease safely.
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Small study tracks life quality during kaposi sarcoma treatment
Symptom relief CompletedThis study looked at how well people with AIDS-related Kaposi sarcoma felt during treatment with two chemotherapy drugs, vincristine and bleomycin. Ten participants in Tanzania filled out quality-of-life surveys over three months. The goal was to understand how the treatment affe…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS 1 POSITIVE
Sponsor: AIDS Malignancy Consortium • Aim: Symptom relief
Last updated May 11, 2026 20:47 UTC